In Re: Orthopedic Bone Screw Products Liability Litigation Alexander Sambolin

246 F.3d 315, 49 Fed. R. Serv. 3d 655, 2001 U.S. App. LEXIS 6458, 2001 WL 377052
CourtCourt of Appeals for the Third Circuit
DecidedApril 16, 2001
Docket99-2054
StatusPublished
Cited by128 cases

This text of 246 F.3d 315 (In Re: Orthopedic Bone Screw Products Liability Litigation Alexander Sambolin) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re: Orthopedic Bone Screw Products Liability Litigation Alexander Sambolin, 246 F.3d 315, 49 Fed. R. Serv. 3d 655, 2001 U.S. App. LEXIS 6458, 2001 WL 377052 (3d Cir. 2001).

Opinion

OPINION OF THE COURT

AMBRO, Circuit Judge

Alexander Sambolin appeals from an order of the United States District Court for the Eastern District of Pennsylvania dismissing his claim as untimely. As a result of the dismissal, Sambolin’s claim fails to qualify for compensation pursuant to the multidistrict class action settlement agreement (the “Settlement Agreement”) between the Appellees — AcroMed Corporation (“AcroMed”) and the Plaintiffs’ Legal Committee (“PLC”) — approved by the District Court in In re: Orthopedic Bone Screw Products Liability Litigation, 176 F.R.D. 158 (E.D.Pa.1997). On appeal, Sambolin presents three arguments that the District Court improperly denied him participation in the mandatory, non-opt-out settlement class. He first maintains that the District Court abused its discretion in denying him participation in the settlement under the equitable doctrine of “excusable neglect,” a doctrine whose label we find unnecessarily pejorative here but whose principles are nonetheless relevant. Sam-bolin next argues that the settlement’s registration deadline, under which his claim is untimely, violates the equal protection and procedural due process protections of the Fifth and Fourteenth Amendments. His final contention on appeal is that the court-approved notice program in this class action was deficient under the standards of Federal Rule of Civil Procedure 23 and due process.

We forgo ruling on the constitutional challenges, for we conclude that the District Court’s ruling was inconsistent with the exercise of sound discretion in denying Sambolin participation in the settlement solely for his failure to comply with the registration deadline imposed. We recognize that deadlines are an integral component of effective consolidation and management of the modern mass tort class action. See, e.g., In re Gypsum Antitrust Cases, 565 F.2d 1123, 1127 (9th Cir.1977). Yet rigid and unquestioned adherence to such limitations belies principles of equity and the court’s role as a fiduciary in class actions when allowing a claimant participation in a settlement works no harm on the conduct of the proceedings and does *317 not significantly prejudice the interests of the parties. In the circumstances this case presents, we reverse the District Court’s order denying Sambolin participation in the AcroMed settlement.

I. JURISDICTION

The District Court exercised diversity jurisdiction over this multidistrict litigation matter pursuant to 28 U.S.C. §§ 1332(a) and 1407. In re: Orthopedic Bone Screw Prods. Liab. Litig., 176 F.R.D. 158, 171 (E.D.Pa.1997). The order denying Sambo-lin participation in the settlement is a final decision of the District Court conferring jurisdiction on this Court pursuant to 28 U.S.C. § 1291.

II. FACTS

The circumstances surrounding the pedi-cle bone screw litigation and resulting settlement by AcroMed have received more complete and eloquent exposition in other opinions than is required in this appeal. See, e.g., In re: Orthopedic Bone Screw Prods. Liab. Litig., 193 F.3d 781, 784-87 (3d Cir.1999). As a result, we cover only the highlights and how they pertain to Sambolin’s claims.

The multidistrict litigation of orthopedic bone screw products liability claims has been directed by the nine-member PLC, which agreed, in December 1996, to settle with one of the principal manufacturers of bone screws — AcroMed. Under the terms of the Settlement Agreement, 1 AcroMed agreed to create a fund of $100 million, plus the proceeds of the bulk of its insurance policies, in return for a complete release from liability by the certified class. 2 Because the $100 million exceeded AcroMed’s earnings or net assets at the time, it was obtained by monetizing AcroMed’s future earnings and was conditioned on the resolution of this action. The District Court granted mandatory, non-opt-out class certification under Fed. R.Civ.P. 23(b)(1) and preliminarily approved the Settlement Agreement on January 16, 1997 in Pretrial Order (“PTO”) No. 724. 3 In re: Orthopedic Bone Screw Prods. Liab. Litig., No. M.D.L. 1014, 1997 WL 303242 (E.D.Pa. January 16, 1997) (hereinafter “PTO 724”). The Court’s final approval of the Settlement Agreement followed on October 17, 1997. In re: Orthopedic Bone Screw, 176 F.R.D. at 186.

The class certified in the settlement included all persons who underwent surgical implanting of AcroMed bone screws through December 31, 1996, a group estimated by the parties to exceed 100,000. Id. at 170-71, 173. These class members were required by the Settlement Agree *318 ment to file two documents to perfect their rights to recovery. First, it required claimants to file a Registration Form by May 1, 1997 to participate in the settlement. PTO 724, ¶ 12. The Registration Form required, inter alia, listing the claimant’s name, address, age, Social Security number, legal representation and date and type of bone screw surgery. Second, the Settlement Agreement required the filing of a Proof of Claim form, which was to be drafted by the later-appointed Claims Administrator to permit an equitable distribution of the settlement fund. The Claims Administrator was appointed in January 1998 and a Proof of Claim form was agreed on by the parties and approved by the Court on January 6, 1999. PTO 1655. The Proof of Claim form contained extensive release and indemnity terms and required claimants to describe and document their medical histories with the AcroMed bone screws in some detail. It further stated that it must be mailed to the Claims Administrator postmarked no later than April 15, 1999. The Court was unequivocal in its statement of the consequence of a failure to file timely both forms. “Settlement Class Members who are AcroMed Orthopedic Bone Screw Recipients and who do not timely Register and submit Claims Forms are not entitled to share in the AcroMed Settlement Fund, [and] are ... barred and enjoined from asserting Settled Claims.” PTO 724, ¶ 12.

Nevertheless, neither of the deadlines for the two forms escaped postponement. The May 1, 1997 Registration Form deadline was pushed back until May 15, 1997 due to administrative difficulties caused by receiving and processing the large volume of registrations. Almost two years later, the Proof of Claim deadline was delayed twice, cumulatively from April 15, 1999 until June 15, 1999, to remedy the difficulties of many claimants documenting their injuries.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
246 F.3d 315, 49 Fed. R. Serv. 3d 655, 2001 U.S. App. LEXIS 6458, 2001 WL 377052, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-orthopedic-bone-screw-products-liability-litigation-alexander-ca3-2001.